IL17A and neoplasm: Interleukin-17 (IL-17) is a cytokine produced primarily by T helper 17 (Th17) cells and its role in cancer is complex and context-dependent, as it can have both pro-tumorigenic and anti-tumorigenic effects, depending on the specific cancer type, stage of disease, and the tumor microenvironment [70].